Rossari Biotech Q1 FY26 Concall Decoded: Revenue +11%, but Institutional Cleaning turned into Institutional Bleeding
1. Opening Hook
When your exports catch a cold and your Institutional Cleaning sneezes, the whole P&L sounds like it’s coughing. Rossari’s Q1 looked like a chemistry lab experiment gone half right — HPPC and Animal Nutrition gave some fizz, but B2C and institutional cleaning fizzled. Still, management swears it’s “consolidation year” before the FY27 fireworks. Should investors keep patience till reactors stop shutting for hot work? Spoiler: the good stuff is buried in CAPEX plans.
EBITDA ₹68 cr (+5%) – Margins fell to 12.5%; Institutional Cleaning loss dragged.
Adj. EBITDA ₹75 cr (+12%) – Core B2B held firm at 16% margin.
PAT muted – Consolidated profits not keeping up with top line.
Exports ₹139 cr – 26% of sales, but weaker sequentially.
Capex spree – Units at Rossari, Unitop & Tristar nearing commissioning; FY28 full bang expected.
3. Management’s Key Commentary
Quote: “We delivered steady growth led by HPPC and AHN, but exports faced headwinds.” (Translation: India saved us, global markets ghosted us.)
Quote: “Institutional Cleaning business reported ~₹7 cr loss.” (Translation: The mop slipped, and we fell flat.)
Quote: “Capacity expansions will deliver 3x–4x asset turns by FY27–28.” (Translation: Today’s pain = tomorrow’s operating leverage party.)
Quote: “EO supply from Reliance delayed, but demand softness gave us breathing space.” (Translation: Lucky break — demand slowdown became our supplier.)
Quote: “Subsidiary margins look weak standalone, but consolidated is fine.” (Translation: Don’t ask Unitop questions, just clap at group numbers.)
Quote: “Exports to be 27–28% of turnover annually.” (Translation: Still betting on foreign shores, though Q1 was a sea of delays.)
Quote: “Targeting break-even in Institutional Cleaning by FY26 end.” (Translation: Hoping the janitors turn profitable by Diwali.) 😏
